Tokyo Tape
Sign in
← Cytori Cell Research Institute

Quarterly report · Q2

3750.TEDINET S100S7YU
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥863m2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥2.1bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥1.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income−¥354m2023-04-01 → 2023-09-30Cons.Operating income
Operating income−¥381m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income−¥424m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income−¥862m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥437m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax−¥419m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax−¥539m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)−¥443m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥1.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥561m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income−¥443m2023-04-01 → 2023-09-30Cons.Profit loss
Net income−¥561m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥13.6bnat 2023-09-30Cons.Assets
Total assets¥14.1bnat 2023-03-31Cons.Assets
Total assets¥14.2bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥11.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥11.4bnat 2023-03-31Cons.Liabilities
Net assets / equity¥2.2bnat 2023-09-30Cons.Net assets
Net assets / equity¥2.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥3.2bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥658mat 2023-09-30Cons.Cash and deposits
Cash and deposits¥1.1bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥208mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥673mat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥561mat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥702mat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥367m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥40m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥20m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥3m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥283m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥94m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥94m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥294m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥67m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.652023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-31.592023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-118.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-62.862022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-30.662022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio14.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio17.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio20.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30−¥87m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2023-04-01 → 2023-09-30¥45m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2023-04-01 → 2023-09-30−¥285m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2023-04-01 → 2023-09-30¥818m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2023-04-01 → 2023-09-30¥17m
—segment totalrevenue2023-04-01 → 2023-09-30¥863m
—segment totalrevenue external2023-04-01 → 2023-09-30¥863m
—segment totalsegment profit2023-04-01 → 2023-09-30−¥267m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥74m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentrevenue external2022-04-01 → 2022-09-30¥84m
jpcrp040300-q2r_E05443-000Medical Asset Managemetreportable segmentsegment profit2022-04-01 → 2022-09-30−¥119m
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E05443-000Real Asset Managementreportable segmentsegment profit2022-04-01 → 2022-09-30−¥188m
—segment totalrevenue2022-04-01 → 2022-09-30¥1.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥1.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30−¥307m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 442
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember1172744000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Revenues from external customersPrior1YTDDuration1172744000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember83682000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember1089062000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember1172744000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Net salesPrior1YTDDuration1172744000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember-118757000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember-187918000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember-306675000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-74309000JPY
Operating incomePrior1YTDDuration-380985000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember44646000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember817885000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember862531000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Revenues from external customersCurrentYTDDuration862531000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember44646000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember817885000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember862531000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Net salesCurrentYTDDuration862531000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E05443-000MedicalAssetManagemetReportableSegmentsMember-284847000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E05443-000RealAssetManagementReportableSegmentsMember17430000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember-267417000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-86654000JPY
Operating incomeCurrentYTDDuration-354071000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-11-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第20期第２四半期（自　2023年７月１日　至　2023年９月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社サイトリ細胞研究所
Company name in english cover pageFilingDateInstantCytori Cell Research Institute,Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　星野　喜宏
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区大手町一丁目１番１号
Telephone number address of registered headquarter cover pageFilingDateInstant03－6860－5701
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役経営企画部長　　藤村　剛
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区大手町一丁目１番１号

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass